Search research articles
Contact Us
Filters
Showing results (171-180 of 209) with videos related to
Page
of 21
Sort By:
Antiviral Therapy
|
June 25, 2008
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Eugenia Vispo, Pablo Barreiro, Juan A Pineda, et al.
The Journal of Antimicrobial Chemotherapy
|
July 27, 2010
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
Juan Macías, José del Valle, Antonio Rivero, et al.
Antiviral Research
|
July 4, 2012
HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection
Karin Neukam, Silvia García-Rey, Celia Cifuentes, et al.
AIDS Research and Human Retroviruses
|
September 13, 2012
Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C
Antonio Rivero-Juarez, Jose A Mira, Ignacio Santos-Gil, et al.
HIV Clinical Trials
|
October 30, 2003
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients
J Fernández-Rivera, R García, F Lozano, et al.
AIDS Research and Human Retroviruses
|
January 3, 2006
Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy
E Ramayo, M P González-Moreno, J Macías, et al.
Archives of Virology
|
August 28, 2014
Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection
F A Di Lello, J A Mira, K Neukam, et al.
AIDS (London, England)
|
May 4, 2011
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse
Pablo Labarga, Pablo Barreiro, José A Mira, et al.
The Science of the Total Environment
|
April 8, 2025
Cataloging olive oil mill wastewater sludge based on toxicological profiles and functional microbial diversity
M R Martínez-Gallardo, R Jiménez, F Suárez-Estrella, et al.
Antiviral Therapy
|
December 4, 2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection
Karin Neukam, Daniela Munteanu, Sebastian Haubitz, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 209) with videos related to
Sort By:
Page
of 21
Antiviral Therapy
|
June 25, 2008
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Eugenia Vispo, Pablo Barreiro, Juan A Pineda, et al.
The Journal of Antimicrobial Chemotherapy
|
July 27, 2010
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
Juan Macías, José del Valle, Antonio Rivero, et al.
Antiviral Research
|
July 4, 2012
HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection
Karin Neukam, Silvia García-Rey, Celia Cifuentes, et al.
AIDS Research and Human Retroviruses
|
September 13, 2012
Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C
Antonio Rivero-Juarez, Jose A Mira, Ignacio Santos-Gil, et al.
HIV Clinical Trials
|
October 30, 2003
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients
J Fernández-Rivera, R García, F Lozano, et al.
AIDS Research and Human Retroviruses
|
January 3, 2006
Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy
E Ramayo, M P González-Moreno, J Macías, et al.
Archives of Virology
|
August 28, 2014
Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection
F A Di Lello, J A Mira, K Neukam, et al.
AIDS (London, England)
|
May 4, 2011
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse
Pablo Labarga, Pablo Barreiro, José A Mira, et al.
The Science of the Total Environment
|
April 8, 2025
Cataloging olive oil mill wastewater sludge based on toxicological profiles and functional microbial diversity
M R Martínez-Gallardo, R Jiménez, F Suárez-Estrella, et al.
Antiviral Therapy
|
December 4, 2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection
Karin Neukam, Daniela Munteanu, Sebastian Haubitz, et al.
Page
of 21